Changeflow GovPing Government General Angiodynamics Soft-Vu Angiographic Catheter Rec...
Urgent Enforcement Amended Final

Angiodynamics Soft-Vu Angiographic Catheter Recall, 65 Units, Guidewire Defect

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

Angiodynamics Inc. is recalling 65 units (13 boxes) of its Soft-Vu Angiographic Catheter (Headhunter configuration, catalog no. 10714040) due to a manufacturing defect in the catheter hub that may prevent an appropriately sized guidewire from passing through the inner diameter. The firm initiated the recall on March 3, 2026, and FDA classified it as Class II.

“The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.”

FDA , verbatim from source
Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Angiodynamics initiated a voluntary Class II recall of its Soft-Vu Angiographic Catheter (Headhunter 4F x 100cm, catalog no. 10714040) after identifying that the affected devices contain a manufacturing defect in the catheter hub that may prevent an appropriately sized guidewire from passing through. FDA determined the root cause to be a nonconforming material or component. The recall covers lot A2725049 totaling 65 units distributed worldwide, including the United States and 23 other countries.

Healthcare facilities holding any units of this lot must immediately cease use, remove affected product from all inventory locations (labs, Central Supply, Shipping and Receiving), segregate and quarantine the devices in a secure location, and arrange return to Angiodynamics. Distributors must relay the recall notification to all sites and clinics that received the product. Facilities performing intravascular diagnostic procedures should verify whether any Soft-Vu Headhunter catheters in their inventory match the affected lot number.

What to do next

  1. Stop using the devices subject to this recall and share the notification to all users of the devices within your facility immediately
  2. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping and Receiving or ANY other location)
  3. Segregate this product in a secure location for return to AngioDynamics, Inc.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall Angiodynamics SoftVu

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall Angiodynamics SoftVu | |

Date Initiated by Firm March 03, 2026
Date Posted April 17, 2026
Recall Status Open , Classified
Recall Number Z-1868-2026
Recall Event ID 98463
510(K)Number K112452 K161596 K173762
Product Classification Catheter, intravascular, diagnostic - Product Code DQO
Product Soft-Vu Angiographic Catheter, Headhunter (1), Non-Braided;

SOFT-VU HH1 4F X 100CM 038 NB 0SH;
Catalog No.: 10714040;
Product/UPN No.: H787107140405 (Box), H787107140400 (Pouch);
Box Quantity: 5 pouches; |
| Code Information | SOFT-VU HH1 4F X 100CM 038 NB 0SH;
Catalog No.: 10714040;
Product/UPN No.: H787107140405 (Box), H787107140400 (Pouch);
UDI-DI: 25051684008102(Box), 15051684008105(Pouch);
Lot No.: A2725049; |
| FEI Number | 1319211 |
| Recalling Firm/
Manufacturer | Angiodynamics, Inc.
603 Queensbury Ave
Queensbury NY 12804-7619 |
| For Additional Information Contact | Kasey Newcomb
978-333-1108 |
| Manufacturer Reason
for Recall | The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub. |
| FDA Determined
Cause | Nonconforming Material/Component |
| Action | On March 3, 2026 URGENT VOLUNTARY MEDICAL DEVICE RECALL letters were sent to customers.
Actions to be taken:
IMMEDIATELY:
1. Stop using the devices subject to this recall and share the notification to all users of the deviceswithin your facility immediately.
2. Provide a copy of this recall notification to all sites or clinics to which you have distributed affectedproduct.
3. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping andReceiving or ANY other location).
4. Segregate this product in a secure location for return to AngioDynamics, Inc.
5. Package and Return the Recalled Product. |
| Quantity in Commerce | 65 units (13 boxes) |
| Distribution | Worldwide distribution - US Nationwide and the countries of Austria, Australia, Belgium, Canada, China, Chile, Curacao, Czech Republic, Germany, Ireland, Israel, Italy, Lebanon, Netherlands, New Zealand, Panama, Slovenia, South Africa, Spain, Sweden, Thailand. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

| 510(K) Database | 510(K)s with Product Code = DQO |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 3rd, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Product quarantine and return Intravascular diagnostic catheter use
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!